Localization of N-acetyltransferases NAT1 and NAT2 in human tissues.

Human acetyl coenzyme A-dependent N-acetyltransferase (EC 2.3.1.5) (NAT) catalyzes the biotransformation of a number of arylamine and hydrazine compounds. NAT isozymes are encoded at 2 loci; one encodes NAT1, formerly known as the monomorphic form of the enzyme, while the other encodes the polymorphic NAT2, which is responsible for individual differences in the ability to acetylate certain compounds. Human epidemiological studies have suggested an association between the "acetylator phenotype" and particular cancers such as those of the bladder and colon. In the present study, NAT1- and NAT2-specific riboprobes were used in hybridization histochemistry studies to localize NAT1 and NAT2 mRNA sequences in formalin-fixed, paraffin-embedded human tissue sections. Expression of both NAT1 and NAT2 mRNA was observed in liver, gastrointestinal tract tissues (esophagus, stomach, small intestine, and colon), ureter, bladder, and lung. In extrahepatic tissues, NAT1 and NAT2 mRNA expression was localized to intestinal epithelial cells, urothelial cells, and the epithelial cells of the respiratory bronchioles. The observed heterogeneity of NAT1 and NAT2 mRNA expression between human tissue types may be of significance in assessing their contribution to known organ-specific toxicities of various arylamine drugs and carcinogens.

[1]  T. Triche,et al.  An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. , 1990, The American journal of pathology.

[2]  J. Brockmöller,et al.  Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. , 1996, Cancer research.

[3]  G. Talaska,et al.  Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Mommsen,et al.  Susceptibility in urinary bladder cancer: acetyltransferase phenotypes and related risk factors. , 1986, Cancer letters.

[5]  J. Brockmöller,et al.  Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. , 1996, Cancer research.

[6]  E. Sim,et al.  N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. , 1991, Biochemical pharmacology.

[7]  D. Grant,et al.  Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. , 1991, Molecular pharmacology.

[8]  D. Grant,et al.  Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes. , 1991, The Journal of pharmacology and experimental therapeutics.

[9]  J. Kolars,et al.  CYP3A gene expression in human gut epithelium. , 1994, Pharmacogenetics.

[10]  R. Khesin,et al.  Molecular Genetics , 1968, Springer Berlin Heidelberg.

[11]  R. Minchin,et al.  Distribution of acetyltransferase activities in the intestines of rapid and slow acetylator rabbits. , 1991, Carcinogenesis.

[12]  F. Guengerich,et al.  Metabolic activation, DNA adducts, and H‐ras mutations in human neoplastic and non‐neoplastic laryngeal tissue , 1993, Journal of cellular biochemistry. Supplement.

[13]  R. Mckinnon,et al.  Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. , 1995, Gut.

[14]  T. Deguchi,et al.  Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. , 1990, The Journal of biological chemistry.

[15]  T. Rustan,et al.  Rodent models of the human acetylation polymorphism: comparisons of recombinant acetyltransferases. , 1997, Mutation research.

[16]  L. Stanley,et al.  Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  D. Hein,et al.  Acetylator genotype-dependent expression of arylamine N-acetyltransferase in human colon cytosol from non-cancer and colorectal cancer patients. , 1991, Cancer research.

[18]  R. Minchin,et al.  N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. , 1992, Biochemical and biophysical research communications.

[19]  R. Tukey,et al.  Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. , 1990, Cancer research.

[20]  D. Hearse,et al.  Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase. , 1973, The Biochemical journal.

[21]  K. Ilett,et al.  Acetylation phenotype in colorectal carcinoma. , 1987, Cancer research.

[22]  D. Grant,et al.  The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies. , 1997, Mutation research.

[23]  T. Rustan,et al.  Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus. , 1991, The Journal of pharmacology and experimental therapeutics.

[24]  D. Bell,et al.  Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. , 1995, Cancer research.

[25]  R. Weaver,et al.  Cytochrome P450 expression in oesophageal cancer. , 1994, Gut.

[26]  I. Mills,et al.  Localization of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice. , 1997, Pharmacogenetics.

[27]  E. Messing,et al.  Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[28]  D. Hein.  Acetylator genotype and arylamine-induced carcinogenesis. , 1988, Biochimica et biophysica acta.

[29]  J. Lo-Guidice,et al.  NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus. , 1997, Pharmacogenetics.

[30]  M. McManus,et al.  Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P4503A proteins in the presence of flavonoids. , 1992, Cancer research.

[31]  H. Sewell,et al.  The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. , 1988, British journal of clinical pharmacology.

[32]  D. Grant,et al.  Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. , 1990, DNA and cell biology.

[33]  S. M. Frederickson,et al.  Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cells. , 1992, Carcinogenesis.

[34]  D. Grant.  Molecular genetics of the N-acetyltransferases. , 1993, Pharmacogenetics.

[35]  W. Thilly,et al.  Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. , 1996, American journal of respiratory cell and molecular biology.

[36]  P. Capel,et al.  Characterization and tissue specificity of a monoclonal antibody against human uridine 5'-diphosphate-glucuronosyltransferase. , 1987, Gastroenterology.

[37]  E. Messing,et al.  Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells. , 1994, Carcinogenesis.

[38]  E. Sim,et al.  N-acetyltransferase in human urothelium and bladder cell lines. , 1991, Biochemical Society transactions.

[39]  Y. Awasthi,et al.  Immunohistochemical localization, purification, and characterization of human urinary bladder glutathione S-transferases. , 1991, Biochimica et biophysica acta.

[40]  D. Grant,et al.  Human acetyltransferase polymorphisms. , 1997, Mutation research.

[41]  I. Stupans,et al.  Immunohistochemical localization of NADPH-cytochrome P450 reductase in human tissues. , 1989, Carcinogenesis.

[42]  J. Morizet,et al.  Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. , 1993, Cancer research.

[43]  R. Tukey,et al.  Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization , 1991, Hepatology.